Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis

Author： Mohiuddin Syed M.   Thakker Kamlesh M.   Setze Carolyn M.   Kelly Maureen T.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.5, 2011-05, pp. : 1067-1078

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

By Kamat Siddhesh A.   Bullano Michael F.   Chang Chun-Lan   Gandhi Sanjay K.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 961-968

Informa Healthcare

Access to resources Recommend Favorite

Impulse control disorder related behaviours during long‐term rotigotine treatment: a post hoc analysis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 23, Iss. 10, 2016-10 ,pp. : 1556-1565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy

By Farnier Michel   Ducobu Jean   Bryniarski Leszek  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2165-2173

Informa Healthcare

Access to resources Recommend Favorite

All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 277-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 277-280

John Wiley & Sons Inc

Access to resources Recommend Favorite